• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

强直性脊柱炎患者发生带状疱疹的风险:一项基于台湾人群的队列研究。

The risk of herpes zoster among patients with ankylosing spondylitis: A population-based cohort study in Taiwan.

作者信息

Wang Shuya, Wei James Cheng-Chung, Huang Jing-Yang, Perng Wuu-Tsun, Zhang Zhiyi

机构信息

Department of Rheumatology, The First Affiliated Hospital of Harbin Medical University, Harbin, China.

Department of Rheumatology, BenQ Medical Center, The Affiliated BenQ Hospital of Nanjing Medical University, Nanjing, Jiangsu, China.

出版信息

Int J Rheum Dis. 2020 Feb;23(2):181-188. doi: 10.1111/1756-185X.13650. Epub 2019 Jul 23.

DOI:10.1111/1756-185X.13650
PMID:31334604
Abstract

OBJECTIVES

The incident rate of herpes zoster (HZ) is higher in some autoimmune diseases; however the relationship of HZ and ankylosing spondylitis (AS) is still unclear. This research aims to determine the incidence of HZ in Taiwan AS patients.

METHODS

This study included 2819 AS patients and 11 276 non-AS controls between 2003 and 2013. All participants were selected from the Longitudinal Health Insurance Database 2000 Taiwan. The endpoint was diagnosis of HZ by International Classification of Diseases, Ninth Revision, Clinical Modification coding for at least 3 outpatient visits or one admission until the end of 2013. We used Chi-square test, Cox proportional hazard models and a Kaplan-Meier analysis to calculate the hazards ratio (HR), disease-free survival and incidental density of HZ. Subgroup analysis and sensitivity tests were also done.

RESULTS

Comorbidities such as chronic urticaria, inflammatory bowel disease, thyroid disorders, hypertension, diabetes mellitus, hyperlipidemia, coronary artery disease, cerebrovascular accident, were higher in patients with AS than that in controls. Patients age ≥60 or comorbid disease such as thyroid disorders or cancer had a higher HR of HZ; the adjusted HRs were 2.273 (95% CI 1.314-3.931), 1.577 (95% CI 1.008-2.466) and 1.855 (95% CI 1.248-2.758) respectively, on multivariable modeling. The crude HR for HZ among AS patient was 1.178 (95% CI 0.953-1.455, P > 0.05), and the adjust HZ was 1.070 (95% CI 0.835-1.371, P > 0.05), compared to non-AS controls.

CONCLUSIONS

There is no difference in incidence rate of HZ between Taiwan AS patients and non-AS controls. Among AS patients, age and cancer were major risk factors for incidental HZ.

摘要

目的

某些自身免疫性疾病中带状疱疹(HZ)的发病率较高;然而,HZ与强直性脊柱炎(AS)之间的关系仍不明确。本研究旨在确定台湾AS患者中HZ的发病率。

方法

本研究纳入了2003年至2013年间的2819例AS患者和11276例非AS对照。所有参与者均选自台湾2000年纵向健康保险数据库。终点是根据国际疾病分类第九版临床修订本编码诊断为HZ,至少有3次门诊就诊或1次住院,直至2013年底。我们使用卡方检验、Cox比例风险模型和Kaplan-Meier分析来计算风险比(HR)、无病生存期和HZ的发病密度。还进行了亚组分析和敏感性测试。

结果

AS患者的慢性荨麻疹、炎症性肠病、甲状腺疾病、高血压、糖尿病、高脂血症、冠状动脉疾病、脑血管意外等合并症高于对照组。年龄≥60岁或患有甲状腺疾病或癌症等合并症的患者HZ的HR较高;在多变量模型中,调整后的HR分别为2.273(95%CI 1.314-3.931)、1.577(95%CI 1.008-2.466)和1.855(95%CI 1.248-2.758)。与非AS对照相比,AS患者中HZ的粗HR为1.178(95%CI 0.953-1.455,P>0.05),调整后的HZ为1.070(95%CI 0.835-1.371,P>0.05)。

结论

台湾AS患者与非AS对照之间HZ的发病率没有差异。在AS患者中,年龄和癌症是偶发性HZ的主要危险因素。

相似文献

1
The risk of herpes zoster among patients with ankylosing spondylitis: A population-based cohort study in Taiwan.强直性脊柱炎患者发生带状疱疹的风险:一项基于台湾人群的队列研究。
Int J Rheum Dis. 2020 Feb;23(2):181-188. doi: 10.1111/1756-185X.13650. Epub 2019 Jul 23.
2
Increased Risk of Inflammatory Bowel Disease Among Patients With Ankylosing Spondylitis: A 13-Year Population-Based Cohort Study.强直性脊柱炎患者炎症性肠病发病风险增加:一项基于人群的 13 年队列研究。
Front Immunol. 2020 Oct 2;11:578732. doi: 10.3389/fimmu.2020.578732. eCollection 2020.
3
Herpes zoster as a risk factor for osteoporosis: A 15-year nationwide population-based study.带状疱疹作为骨质疏松症的一个风险因素:一项基于全国人口的15年研究。
Medicine (Baltimore). 2016 Jun;95(25):e3943. doi: 10.1097/MD.0000000000003943.
4
Increased Incidence of Herpes Zoster and Postherpetic Neuralgia in Adult Patients following Traumatic Brain Injury: A Nationwide Population-Based Study in Taiwan.创伤性脑损伤后成年患者带状疱疹和带状疱疹后神经痛发病率增加:台湾一项基于全国人口的研究
PLoS One. 2015 Jun 11;10(6):e0129043. doi: 10.1371/journal.pone.0129043. eCollection 2015.
5
High prevalence of herpes zoster in patients with depression.抑郁症患者中带状疱疹的高患病率。
J Clin Psychiatry. 2015 Sep;76(9):e1099-104. doi: 10.4088/JCP.14m09311.
6
The Incidence and Risk of Herpes Zoster in Patients With Sleep Disorders: A Population-Based Cohort Study.睡眠障碍患者带状疱疹的发病率和风险:一项基于人群的队列研究。
Medicine (Baltimore). 2016 Mar;95(11):e2195. doi: 10.1097/MD.0000000000002195.
7
Increased incidence of herpes zoster in adult patients with peptic ulcer disease: a population-based cohort study.消化性溃疡病成年患者带状疱疹发病率增加:一项基于人群的队列研究。
Int J Epidemiol. 2013 Dec;42(6):1873-81. doi: 10.1093/ije/dyt213.
8
Risk of herpes zoster among patients with predialysis chronic kidney disease in a cohort study in Taiwan.台湾一项队列研究中透析前慢性肾脏病患者带状疱疹发病风险。
Int J Clin Pract. 2020 Oct;74(10):e13566. doi: 10.1111/ijcp.13566. Epub 2020 Jul 14.
9
Increased Risk of Herpes Zoster in Young and Metabolically Healthy Patients with Inflammatory Bowel Disease: A Nationwide Population-Based Study.炎症性肠病患者中年轻且代谢健康者患带状疱疹的风险增加:一项全国性基于人群的研究。
Gut Liver. 2019 May 15;13(3):333-341. doi: 10.5009/gnl18304.
10
No increased risk of alopecia in ankylosing spondylitis patients: A population-based cohort study in Taiwan.台湾基于人群的队列研究:强直性脊柱炎患者脱发风险无增加。
Int J Rheum Dis. 2022 Aug;25(8):937-944. doi: 10.1111/1756-185X.14393. Epub 2022 Jul 26.

引用本文的文献

1
The Risk of Herpes Zoster Events in Patients with Spondyloarthritis and the Effect of BNT162b2 mRNA COVID-19 Vaccine.脊柱关节炎患者发生带状疱疹事件的风险及BNT162b2 mRNA新冠疫苗的影响
Vaccines (Basel). 2024 Jan 15;12(1):85. doi: 10.3390/vaccines12010085.
2
Risk factors for herpes zoster infections: a systematic review and meta-analysis unveiling common trends and heterogeneity patterns.疱疹性感染的风险因素:系统综述和荟萃分析揭示了常见趋势和异质性模式。
Infection. 2024 Jun;52(3):1009-1026. doi: 10.1007/s15010-023-02156-y. Epub 2024 Jan 18.
3
The Epidemiology and Treatment of Ankylosing Spondylitis in Korea.
韩国强直性脊柱炎的流行病学与治疗
J Rheum Dis. 2022 Oct 1;29(4):193-199. doi: 10.4078/jrd.22.0023. Epub 2022 Sep 22.
4
The Risk of Major Adverse Cardiovascular Events in Ankylosing Spondylitis Patients With a History of Acute Anterior Uveitis: A Nationwide, Population Based Cohort Study.有急性前葡萄膜炎病史的强直性脊柱炎患者发生重大不良心血管事件的风险:一项基于全国人群的队列研究
Front Med (Lausanne). 2022 Jul 7;9:884800. doi: 10.3389/fmed.2022.884800. eCollection 2022.
5
Safety and Efficacy of Upadacitinib in Patients With Active Ankylosing Spondylitis and an Inadequate Response to Nonsteroidal Antiinflammatory Drug Therapy: One-Year Results of a Double-Blind, Placebo-Controlled Study and Open-Label Extension.乌帕替尼治疗非甾体抗炎药应答不足的活动性强直性脊柱炎患者的安全性和疗效:一项双盲、安慰剂对照研究和开放标签扩展的一年结果。
Arthritis Rheumatol. 2022 Jan;74(1):70-80. doi: 10.1002/art.41911. Epub 2021 Nov 12.